Why Farbe Firma is the Top Manufacturer of Famotidine for Injection
- Maulik Sudani
- 1 hour ago
- 4 min read
Last Updated: May 18, 2026
TL;DR: Farbe Firma Pvt Ltd, a WHO-GMP certified pharmaceutical manufacturer in Ankleshwar, Gujarat, India, is one of the most trusted producers and CMO partners for Famotidine for Injection, supplying sterile lyophilized and ready-to-use product to hospitals, ICU pharmacies, distributors and government tenders across 30+ countries.
Key Takeaways
Famotidine for Injection is a parenteral H2-receptor antagonist used in acute upper-GI bleed, stress-ulcer prophylaxis in ICU patients, and pre-anaesthetic gastric acid control.
Farbe Firma is a WHO-GMP certified, ISO 9001:2015 compliant manufacturer with ISO Class 5 (Grade A) sterile core and 100+ injectable SKUs.
CTD/ACTD-dossier-supported famotidine vials and ampoules are exported to 30+ countries across Latin America, CIS, Africa, the Middle East and South-East Asia.
Full CMO/CDMO services: formulation R&D, lyophilization, scale-up, ICH stability, primary/secondary packaging and regulatory support under one roof in Gujarat, India.
Introduction: Why Famotidine for Injection Demands a Premium Manufacturer
Famotidine for Injection is a parenteral histamine H2-receptor antagonist used to reduce gastric acid secretion in patients who cannot take oral therapy - particularly ICU patients on stress-ulcer prophylaxis, post-operative cases, patients with upper-GI bleeding, and obstetric patients prior to general anaesthesia. Every vial must satisfy USP / BP / IP / EP monograph requirements for assay, related substances, particulate matter, bacterial endotoxin (LAL) and sterility, with reconstitution and stability data that match real-world hospital handling.
That is exactly the operating bar Farbe Firma Pvt Ltd has set since establishing its WHO-GMP certified sterile injectable facility in Ankleshwar, Gujarat, India. With ISO Class 5 (Grade A) aseptic filling under ISO Class 7 background, validated lyophilization cycles where required, end-to-end batch traceability and a dedicated H2-blocker production block, Farbe Firma has become a preferred Famotidine for Injection manufacturer for hospital procurement chains, importers and government tender buyers worldwide.
What Sets a World-Class Famotidine Manufacturer Apart
Manufacturing parenteral famotidine is more demanding than producing oral tablets. The product must pass clarity, sub-visible particulate (USP <788>), bacterial endotoxin (LAL), sterility and assay tests at every batch - and every step is reviewed by the in-house Quality Assurance team before any vial is released. Farbe Firma's famotidine line uses Type I borosilicate glass vials with chlorobutyl stoppers, validated aseptic filling and 100% visual plus automated particulate inspection.
Equally important is regulatory readiness. Famotidine for Injection is registered as a prescription parenteral in most jurisdictions, so buyers need a manufacturer who can supply CTD or ACTD dossiers, country-specific labeling artwork, certificates of analysis (CoA), certificates of origin and free-sale certificates without delay. Farbe Firma's regulatory affairs team has supported dossier submissions and product registrations across Latin America, Africa, the GCC, CIS and ASEAN - making us a CDMO partner rather than just a vendor.
Quality Systems Behind Every Famotidine Vial
Each batch of Famotidine for Injection at Farbe Firma passes through tightly controlled in-process checks: pre-sterilization bioburden, fill-volume verification, post-fill leak testing, lyo cycle validation where applicable, container-closure integrity testing and finished-product assay against the relevant pharmacopoeia. Stability programs run at 25C/60% RH and 40C/75% RH per ICH Q1A(R2) guidelines, supporting 24- to 36-month shelf life claims.
Documentation includes batch manufacturing records (BMR), batch packaging records (BPR), validated cleaning records, environmental monitoring data and qualified-person review - all retained and reproducible for any future audit. The same SOPs apply whether the product is destined for a domestic hospital chain or a Ministry of Health tender in West Africa.
Why Farbe Firma is the Trusted Famotidine for Injection Manufacturer for Global Buyers
Farbe Firma Pvt Ltd is a WHO-GMP certified, ISO 9001:2015 compliant pharmaceutical manufacturer headquartered in Gujarat, India. The facility is designed around dedicated injectable suites with ISO Class 5 sterile core, water-for-injection (WFI) loop validated for endotoxin and conductivity, and validated terminal sterilization for ampoules plus aseptic filling for vials. The plant supplies 100+ injectable SKUs and exports to 30+ countries across five continents.
Beyond manufacturing, Farbe Firma operates as a true CDMO. We support contract development from formulation through validation, scale-up, dossier preparation, product registration assistance and life-cycle management. For famotidine, our regulatory team works in close coordination with the buyer's national health authority to ensure import licensing, pharmacopoeial compliance, hospital tender qualification and post-market pharmacovigilance requirements are satisfied.
Pricing, lead-time and minimum-order-quantity (MOQ) flexibility are why distributors, hospital groups and government tender buyers choose Farbe Firma year after year. Whether you need a one-time tender shipment or a multi-year supply agreement under a master CMO contract, the answer is the same: WHO-GMP quality, on-time delivery, complete documentation, and a partner who treats your market like our own.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma's Famotidine for Injection WHO-GMP certified?
Yes. The entire injectable facility where Famotidine for Injection is manufactured operates under valid WHO-GMP certification, ISO 9001:2015 quality management, and ISO Class 5 sterile core conditions. Certificates and inspection reports are available on request.
What vial sizes and strengths are available?
Standard configurations include 20 mg/2 mL clear Type I glass vials, ready-to-use formats and lyophilized presentations on request. Custom strengths, fill volumes and country-specific carton/leaflet artwork are available subject to MOQ and regulatory feasibility.
Do you provide CTD/ACTD dossiers for Famotidine for Injection?
Yes. Our regulatory affairs team prepares complete CTD or ACTD dossiers - including module 3 quality data, stability summaries, container-closure integrity data and CMC sections - to support product registration in Latin America, CIS, MENA, ASEAN and African markets.
Is Famotidine for Injection suitable for ICU stress-ulcer prophylaxis tenders?
Yes. Farbe Firma's Famotidine for Injection is routinely supplied into Ministry of Health and large hospital tenders for ICU and surgical use across Latin America, CIS, Africa and South-East Asia, with full documentation including CoA, CPP, free-sale certificate and country-specific labeling.
What is the minimum order quantity and lead time for Famotidine for Injection?
Typical MOQ starts from 20,000 vials per SKU; lead time ranges 6-10 weeks from purchase order subject to API availability and country-specific artwork approval. Faster lead times are possible for repeat orders under a CMO framework agreement.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | director@farbefirma.org | Gujarat, INDIA
Comments